conduct
systemat
review
across
databas
includ
chines
databas
follow
approach
detail
prisma
prefer
report
item
systemat
review
metaanalys
guidelin
tailor
search
strategi
develop
use
search
medlin
embas
global
health
lilac
china
nation
knowledg
infrastructur
cnki
wanfang
data
chongq
vip
databas
appendix
search
refer
list
relev
articl
elig
articl
search
limit
januari
august
public
statu
criteria
languag
restrict
use
includ
studi
fulfil
follow
select
criteria
supplementari
figur
three
investig
conduct
independ
search
englishlanguag
literatur
extract
data
use
standard
data
extract
templat
one
investig
whose
first
languag
chines
search
extract
data
chineselanguag
databas
ie
cnki
wanfang
cqvip
protocol
review
publish
prospero
databas
case
group
defin
older
adult
ari
pneumonia
age
year
adapt
world
health
organ
integr
manag
adolesc
adult
ill
detail
definit
display
supplementari
tabl
control
group
defin
older
adult
age
year
either
healthi
respiratori
symptom
categor
countri
either
industri
develop
basi
criteria
unit
nation
children
fund
calcul
odd
ratio
or
ratio
odd
detect
viru
older
adult
ari
pneumonia
odd
detect
viru
healthi
asymptomat
control
accompani
confid
interv
ci
use
continu
correct
viru
detect
one
group
allow
calcul
instanc
enabl
inclus
subsequ
metaanalys
use
stata
version
perform
metaanalysi
virusspecif
or
report
pool
metaestim
correspond
ci
use
random
effect
model
ie
dersimonianlaird
method
includ
studi
heterogen
variou
aspect
thu
assum
differ
effect
size
virusspecif
attribut
fraction
among
expos
afe
use
quantifi
etiolog
role
viru
patient
ari
estim
percentag
ari
attribut
viru
absolut
term
calcul
ci
correspond
ci
moreov
specif
viru
includ
studi
report
viru
detect
one
group
consist
usual
control
group
assum
strong
associ
indic
possibl
causal
role
viru
ari
could
conclud
circumst
consid
need
run
metaanalysi
would
result
extrem
high
point
estim
afe
approach
identifi
chines
databas
record
literatur
search
record
refer
list
relev
articl
among
studi
includ
chines
databas
fulfil
inclus
exclus
criteria
figur
fortythre
studi
exclud
varieti
reason
data
specif
older
adult
year
old
avail
n
case
control
definit
fulfil
n
applic
data
case
control
report
n
serum
use
clinic
specimen
n
seven
studi
conduct
within
develop
countri
develop
countri
supplementari
tabl
although
search
perform
articl
publish
sinc
includ
studi
publish
sinc
includ
studi
casecontrol
studi
adult
ari
pneumonia
case
group
asymptomat
healthi
adult
control
group
method
vari
among
studi
among
case
definit
use
studi
use
ari
acut
lower
respiratori
tract
infect
other
use
sever
pneumonia
n
studi
investig
control
group
respiratori
symptom
studi
healthi
older
adult
without
acut
ill
serv
control
case
ascertain
method
use
articl
recruit
case
inpati
outpati
gener
practic
commun
mix
set
outpati
set
emerg
depart
outpati
inpati
set
studi
control
ascertain
hospitalbas
outpati
clinic
site
wherea
studi
control
identifi
commun
studi
collect
mixtur
nasopharyng
swab
specimen
nasopharyng
aspir
nasopharyng
wash
oropharyng
swab
specimen
nasalthroat
swab
specimen
clinic
specimen
studi
use
polymeras
chain
reaction
analysi
pcr
pcr
combin
serolog
analysi
cultur
diagnost
test
metaanalys
virusspecif
or
report
well
correspond
attribut
fraction
among
expos
supplementari
tabl
rsv
flu
includ
flu
hmpv
rv
cov
also
cov
significantli
common
older
adult
diagnosi
ari
pneumonia
asymptomat
healthi
control
or
ci
ci
ci
ci
ci
respect
virus
statist
signific
posit
afe
show
clear
associ
virus
ari
pneumonia
older
adult
moreov
piv
includ
data
avail
flu
b
adv
identifi
case
consist
across
includ
studi
studi
respect
absent
control
group
thu
virus
assum
strong
associ
ari
studi
data
avail
bov
although
report
viru
detect
greater
proport
case
control
associ
remain
question
research
subgroup
analysi
perform
explor
role
virus
ari
respect
region
develop
countri
industri
countri
metaestim
higher
industri
countri
compar
develop
countri
case
flu
overlap
ci
similar
piv
adv
rv
insuffici
studi
conduct
similar
subgroup
analysi
virus
sensit
analysi
perform
investig
role
common
virus
older
adult
admit
hospit
ari
pneumonia
eight
studi
includ
result
present
supplementari
tabl
metaestim
differ
significantli
previou
estim
case
set
ie
outpati
gener
practic
set
also
includ
first
systemat
review
evalu
summar
literatur
includ
concurr
control
data
viral
etiolog
ari
older
adult
review
summar
data
case
ari
older
adult
report
across
studi
demonstr
strong
evid
support
potenti
causal
attribut
viru
identifi
older
adult
present
ari
pneumonia
rsv
ci
afe
flu
ci
afe
piv
avail
na
afe
approxim
hmpv
ci
afe
adv
na
afe
approxim
rv
ci
afe
cov
ci
afe
support
etiolog
role
rsv
flu
piv
hmpv
adv
rv
cov
ari
pneumonia
older
adult
therebi
indic
potenti
substant
reduct
number
ari
case
older
adult
vaccin
virus
treat
antivir
respiratori
virus
studi
role
bov
ari
pneumonia
uncertain
limit
evid
avail
publish
literatur
requir
research
clarifi
role
older
adult
ari
sensit
analysi
focus
older
adult
admit
hospit
ari
pneumonia
differ
significantli
estim
patient
set
consid
might
result
limit
number
studi
avail
provid
robust
sensit
analysi
studi
calcul
adjust
or
account
confound
effect
age
season
might
compromis
actual
associ
consid
studi
design
futur
research
find
inform
result
studi
seek
estim
global
region
nation
burden
diseas
due
virus
older
adult
show
rsv
flu
piv
hmpv
adv
rv
cov
import
caus
ari
older
adult
diseas
burden
estim
take
account
appropri
afe
estim
older
adult
report
rather
afe
estim
children
age
year
consider
intern
attent
rsvassoci
ari
older
adult
time
novel
vaccin
antivir
strategi
evalu
priorit
moreaccur
diseas
burden
estim
use
result
would
help
inform
futur
polici
intervent
preval
viru
detect
etiolog
studi
pneumonia
adult
substanti
lower
detect
rate
studi
children
epic
etiolog
pneumonia
commun
studi
team
show
virus
detect
adult
hospit
communityacquir
pneumonia
compar
children
admit
hospit
sever
reason
low
level
detect
inabl
obtain
lower
respiratori
tract
specimen
use
diagnost
test
insuffici
sensit
absenc
appropri
diagnost
test
method
undetect
viru
time
studi
presenc
unknown
pathogen
identifi
low
rate
viru
detect
among
adult
hospit
pneumonia
highlight
need
moresensit
diagnost
approach
innov
discoveri
pathogen
assess
virus
past
histori
week
presenc
diseas
moreov
chronic
obstruct
pulmonari
diseas
copd
exacerb
import
caus
ari
hospit
admiss
studi
includ
copd
etiolog
data
inform
unclear
remain
studi
might
underestim
role
viral
infect
patient
previou
etiolog
review
focus
young
children
age
year
show
rsv
flu
includ
flu
piv
hmpv
rv
significantli
common
children
hospit
acut
lower
respiratori
tract
infect
asymptomat
control
associ
virus
except
rsv
ari
pneumonia
stronger
among
adult
part
comparison
young
children
detect
virus
control
group
ie
among
individu
without
respiratori
symptom
healthi
control
less
common
older
adult
except
rsv
sever
methodolog
issu
could
affect
result
sampl
size
age
group
case
ascertain
clinic
specimen
diagnost
test
although
thorough
search
perform
across
databas
includ
chineselanguag
databas
studi
publish
literatur
identifi
met
select
criteria
everi
viru
interest
test
studi
number
studi
avail
even
smaller
subgroup
analys
sensit
analys
perform
moreov
sampl
size
vari
adult
case
group
adult
control
group
small
sampl
size
undoubtedli
contribut
imprecis
ci
around
or
thu
may
fail
detect
clinic
signific
ariviru
associ
owe
small
sampl
size
aim
stratifi
associ
common
respiratori
virus
adult
ari
pneumonia
age
howev
articl
stratifi
report
data
age
group
instead
summar
result
entir
age
group
usual
adult
age
year
therefor
metaestim
or
may
repres
older
adult
age
year
sinc
age
might
risk
factor
ari
adult
rate
sever
ari
increas
age
advanc
could
potenti
affect
viral
profil
detect
introduc
heterogen
fifteen
studi
use
passiv
clinic
hospit
base
case
ascertain
among
case
recruit
inpati
outpati
emerg
depart
gener
practic
might
reflect
differ
healthcar
behavior
diseas
sever
also
sinc
episod
ari
pneumonia
diagnos
routin
care
introduc
bia
consid
test
done
clinician
deem
necessari
test
similarli
studi
use
communitybas
control
anoth
studi
recruit
older
adult
control
hospit
gener
practic
hospit
clinic
ascertain
control
may
reflect
gener
popul
may
health
condit
potenti
affect
viral
carriag
moreov
recruit
control
select
healthi
without
respiratori
symptom
could
favor
expos
respiratori
viru
yield
fals
high
therefor
consid
ideal
control
group
studi
would
random
sampl
age
sexmatch
popul
older
adult
area
resid
studi
time
case
includ
studi
obtain
upper
respiratori
tract
specimen
describ
nasopharyng
secret
assay
might
specimenspecif
sensit
specif
detect
virus
could
lead
heterogen
estim
virusspecif
rate
sensit
use
nasopharyng
wash
detect
viru
adult
found
higher
use
nasopharyng
swab
specimen
turn
higher
use
oropharyng
swab
specimen
respect
limit
use
due
ethic
concern
feasibl
invas
procedur
obtain
lower
respiratori
tract
specimen
directli
lung
also
influenc
diagnosi
viral
infect
adult
ari
pcr
serologybas
diagnost
test
sensit
detect
respiratori
virus
method
antigen
detect
cultur
high
sensit
import
accur
assess
etiolog
contribut
particularli
older
adult
may
lower
nasopharyng
viral
load
atyp
clinic
present
moreov
despit
uncommon
detect
viral
coinfect
rang
across
studi
may
tend
overst
contribut
individu
respiratori
virus
although
dual
multipl
infect
sever
virus
etiolog
import
possibl
bacteri
coinfect
rang
across
studi
also
report
improv
diagnost
method
multipl
etiolog
agent
increasingli
identifi
simultan
older
adult
ari
make
individu
contribut
agent
difficult
defin
virus
detect
individu
respiratori
symptom
often
seen
volunt
challeng
studi
commun
survey
detect
virus
control
group
without
respiratori
symptom
might
due
nascent
infect
persist
colon
previou
infect
factor
tend
result
true
associ
attenu
fact
molecular
detect
virus
older
adult
ari
higher
detect
rate
control
without
respiratori
symptom
may
necessarili
indic
causat
altern
explan
consid
first
causal
conclud
includ
respiratori
viral
infect
act
socal
innoc
bystand
without
causal
role
serv
predispos
risk
factor
ari
similarli
absenc
posit
associ
afe
mean
viru
caus
ari
moreov
without
establish
tempor
sequenc
exposur
outcom
determin
causal
less
secur
therefor
associ
virus
ari
pneumonia
interpret
care
conclus
review
provid
clear
evid
suggest
potenti
causal
role
rsv
flu
piv
hmpv
adv
rv
cov
older
adult
ari
present
first
estim
proport
ari
case
attribut
viru
exposur
etiolog
studi
simpli
report
rate
viral
identif
causal
make
attempt
interpret
find
term
proport
ari
case
among
older
adult
respiratori
viru
identifi
attribut
viral
exposur
resceu
investig
follow
harish
nair
harri
campbel
ting
shi
shanshan
zhang
li
univers
edinburgh
peter
openshaw
jadwicha
wedzicha
imperi
colleg
london
ann
falsey
univers
rochest
mark
miller
nation
institut
philipp
beutel
universiteit
antwerpen
loui
bont
univers
medic
center
utrecht
andrew
pollard
univers
oxford
eva
molero
synaps
federico
martinontorr
servicio
galego
de
saud
terho
heikkinen
turku
univers
central
hospit
adam
meijer
nation
institut
public
health
environ
thea
fischer
staten
serum
institut
maarten
van
den
berg
academisch
ziekenhui
groningen
carlo
giaquinto
penta
foundat
rafael
mikolajczyk
martinluth
univers
hallewittenberg
judi
hackett
eskind
tafess
astrazeneca
bing
cai
charl
knirsch
pfizer
antonio
gonzalez
lopez
ils
dieussaert
nadia
dermateau
sonia
stoszek
glaxosmithklin
scott
gallichan
alexia
kieffer
clariss
demont
sanofi
pasteur
arnaud
cheret
sandra
gavart
jeroen
aerssen
veroniqu
wyffel
matthia
cleenewerck
janssen
robert
fuent
brian
rosen
novavax
